Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

PURPOSE: Prognostic models for overall survival (OS) for patients with metastatic castration-resistant prostate cancer (mCRPC) are dated and do not reflect significant advances in treatment options available for these patients. This work developed and validated an updated prognostic model to predict...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Halabi, Susan, Lin, Chen-Yen, Kelly, W. Kevin, Fizazi, Karim S., Moul, Judd W., Kaplan, Ellen B., Morris, Michael J., Small, Eric J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2014
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3927736/
https://ncbi.nlm.nih.gov/pubmed/24449231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.52.3696
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars